Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Biomoneta Avata Rx

K-Number: K251872 · 2025-11-14

Decision Date2025-11-14
Product CodeFRF
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Biomoneta Avata Rx is a medical device manufactured by Biomoneta Research Private Limited. It received FDA 510(k) clearance on 2025-11-14 under approval number K251872. The device is classified under product code FRF. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Biomoneta Avata Rx?

Biomoneta Avata Rx is a medical device that received FDA 510(k) clearance on 2025-11-14. It is manufactured by Biomoneta Research Private Limited. The 510(k) number is K251872.

When was Biomoneta Avata Rx approved by the FDA?

Biomoneta Avata Rx received FDA 510(k) clearance on 2025-11-14, under approval number K251872.

What company makes Biomoneta Avata Rx?

Biomoneta Avata Rx is manufactured by Biomoneta Research Private Limited.

What is the FDA product code for Biomoneta Avata Rx?

The FDA product code for Biomoneta Avata Rx is FRF.

Related Devices (Code: FRF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.